⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NXGL News
NexGel, Inc Common Stock
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
globenewswire.com
CELU
NXGL
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
globenewswire.com
CELU
CELUW
NXGL
Form 8-K
sec.gov
NXGL
NXGLW
NEXGEL Signs Definitive Agreement to License and Acquire Transformative Portfolio of Commercial-Stage Regenerative Biomaterial Products
globenewswire.com
CELU
NXGL
NEXGEL Announces Financing of $1.797 Million Relating to an Acquisition Targeted to Close in the First Quarter of 2026, Subject to the Completion of Due Diligence
globenewswire.com
NXGLW
NXGL
NexGelRx Receives Additional Investment from Eric Gruntfest of Diesis Holdings, LLC and Appoints Him as Board Observer and Strategic Advisor
globenewswire.com
NXGL
NEXGEL Announces Spin-Off of Drug Delivery Program into NexGelRx
globenewswire.com
NXGL
NEXGEL Reports Third Quarter 2025 Financial Results
globenewswire.com
NXGL